Advanced Search

Extrapulmonary Disorders & Therapeutic Interventions Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Carlo Agostini

    Carlo Agostini

    Medicina Clinica e Sperimentale, Università di Padova, Padova, Italy

  • Photo of Andre Cantin

    Andre Cantin

    Pulmonary Research Unit, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada

  • Photo of Athol Wells

    Athol Wells

    Department of Respiratory Medicine, Royal Brompton & Harefield NHS Trust, London, UK

Section Topics

  • » Chest wall disorders
  • » Hyperbaric oxygen therapy & decompression sickness
  • » Idiopathic pulmonary fibrosis
  • » Interventional bronchoscopy
  • » Lung transplantation
  • » Muscular dystrophy; diaphragm disorders
  • » Pleural diseases
  • » Stem cells, gene therapy & the lung

LATEST EVALUATION

This study is interesting as it compares the effect of two agents, sunitinib and sorafenib, currently in use as anti-tumour drugs, on the development of systemic sclerosis (SSc). Both drugs are broad-spectrum tyrosine-kinase inhibitors (TKis...

Darryl Knight, University of British Columbia, Canada. F1000 Respiratory Disorders

6 Recommended

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

6
Sunitinib inhibits the phosphorylation of PDGF-receptor beta in the skin of mice with scleroderma-like features and prevents the development of the disease.

Kavian N, Servettaz A, Marut W, Nicco C, Chéreau C, Weill B, Batteux F. Arthritis Rheum. 2011 Dec 27

1 Evaluation, most recent by

Darryl Knight, University of British Columbia, Canada. F1000 Respiratory Disorders

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000